Open Access#12015
Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: Summary of WHO recommendations
Dua, Tarun; Barbui, Corrado; Clark, Nicolas; Fleischmann, Alexandra; Poznyak, Vladimir; Van Ommeren, Mark H; Yasamy, Mohammad Taghi; Ayuso Mateos, José Luis
Dua, Tarun; Barbui, Corrado; Clark, Nicolas; Fleischmann, Alexandra; Poznyak, Vladimir; Van Ommeren, Mark H; Yasamy, Mohammad Taghi; Ayuso Mateos, José Luis; Birbeck, Gretchen Lano; Drummond, Colin; Freeman, Melvyn; Giannakopoulos, Pantéléimon; Levav, Itzhak; Obot, Isidore S; Omigbodun, Olayinka; Patel, Vikram; Phillips, Michael; Prince, Martin J; Rahimi-Movaghar, Afarin; Rahman, Atif M; Sander, Ley; Saunders, John B; Servili, Chiara; Rangaswamy, Thara; Unützer, Jürgen; Ventevogel, Peter; Vijayakumar, Lakshmi; Thornicroft, Graham; Saxena, Shekhar P
Funding for the mhGAP Programme, under which the work reported in this manuscript was done, was provided by the following: American Psychiatric Foundation, USA; Association of Aichi Psychiatric Hospitals, Japan; Autism Speaks, USA; CBM; Government of Italy; Government of Japan; Government of The Netherlands; International Bureau for Epilepsy; International League Against Epilepsy; Medical Research Council, UK; National Institute of Mental Health, USA; Public Health Agency of Canada, Canada; Rockefeller Foundation, USA; Shirley Foundation, UK; Syngenta, Switzerland; United Nations Population Fund;World Psychiatric Association
